Citation Impact
Citing Papers
Evaluation of a Single-Dose Nucleoside-Modified Messenger RNA Vaccine Encoding Hendra Virus-Soluble Glycoprotein Against Lethal Nipah virus Challenge in Syrian Hamsters
2019 StandoutNobel
Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA)
2017 Standout
Discovery and functional interrogation of SARS-CoV-2 RNA-host protein interactions
2021 StandoutNobel
Molecular analysis of the BRCA1 and BRCA2 genes in 32 breast and/or ovarian cancer Spanish families
2000
Modeling pathogenesis of emergent and pre-emergent human coronaviruses in mice
2018
Genetic predisposition and environmental risk factors to pancreatic cancer: A review of the literature
2008
Frequency of Breast Cancer Attributable to <EMPH TYPE="ITAL">BRCA1</EMPH> in a Population-Based Series of American Women
1998
Neuroinflammation in Parkinson's disease: a target for neuroprotection?
2009 Standout
Pancreatic cancer
2004 Standout
Genetic Influences on Cystic Fibrosis Lung Disease Severity
2013
Cytokine gene polymorphisms and sudden infant death syndrome
2010
K-ras Mutations and Benefit from Cetuximab in Advanced Colorectal Cancer
2008 Standout
Targeting IL-8 in colorectal cancer
2012
Rethinking cystic fibrosis pathology: the critical role of abnormal reduced glutathione (GSH) transport caused by CFTR mutation
2001
Mycobacterium tuberculosis, macrophages, and the innate immune response: does common variation matter?
2007
Variation in the Untranslated Genome and Susceptibility to Infections
2018
Cystic fibrosis
2016 Standout
The Human Cathelicidin LL-37 Has Antiviral Activity against Respiratory Syncytial Virus
2013 StandoutNobel
An Official ATS Clinical Practice Guideline: Interpretation of Exhaled Nitric Oxide Levels (F e NO ) for Clinical Applications
2011 Standout
NADPH oxidase activity of neutrophil specific granules: requirements for cytosolic components and evidence of assembly during cell activation
2004
Genotype and Phenotype in Cystic Fibrosis
2000
Survival After Prolonged Submersion in Freshwater in Florida
2004
Dexamethasone inhalations in RSV bronchiolitis: A double‐blind, placebo‐controlled study
2005
Effect of genotype on phenotype and mortality in cystic fibrosis: a retrospective cohort study
2003
Influence of tumour micro-environment heterogeneity on therapeutic response
2013 StandoutNature
Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice
2005 Standout
The Burden of Respiratory Syncytial Virus Infection in Young Children
2009 Standout
Hereditary ovarian carcinoma: Heterogeneity, molecular genetics, pathology, and management
2009
Microbial translocation is a cause of systemic immune activation in chronic HIV infection
2006 Standout
Breast cancer risk associated with BRCA1 and BRCA2 in diverse populations
2007
Inherited Cancer Syndromes in Children and Young Adults
2010
American Cancer Society Guidelines for Breast Screening with MRI as an Adjunct to Mammography
2007 Standout
Association of variant alleles of mannose binding lectin with severity of pulmonary disease in cystic fibrosis: cohort study
1999
Local and systemic mechanisms linking periodontal disease and inflammatory comorbidities
2021 Standout
The NOX Family of ROS-Generating NADPH Oxidases: Physiology and Pathophysiology
2007 Standout
A CFTR Potentiator in Patients with Cystic Fibrosis and the G551D Mutation
2011 Standout
Preventing or reducing late side effects of radiation therapy: radiobiology meets molecular pathology
2006 Standout
Bacterial biofilms: from the Natural environment to infectious diseases
2004 Standout
Glutathione Metabolism and Its Implications for Health
2004 Standout
Pharmacological approaches for the discovery and development of new anti-inflammatory agents for the treatment of cystic fibrosis
2002
Fluorescent and colorimetric probes for detection of thiols
2010 Standout
Relationship of viral infections to wheezing illnesses and asthma
2002
The DNA Damage Response: Making It Safe to Play with Knives
2010 Standout
The development of allergic inflammation
2008 StandoutNature
Antimicrobial therapy for pulmonary pathogenic colonisation and infection by Pseudomonas aeruginosa in cystic fibrosis patients
2005
Male breast cancer
2006 Standout
Cyclin D1 and epidermal growth factor polymorphisms associated with survival in patients with advanced colorectal cancer treated with Cetuximab
2006
Cystic fibrosis genetics: from molecular understanding to clinical application
2014 Standout
Risk of Endometrial Carcinoma Associated with BRCA Mutation
2001
Asthma phenotypes: the evolution from clinical to molecular approaches
2012 Standout
Immunopathology of RSV infection: prospects for developing vaccines without this complication
2006
A Common Polymorphism in the Interleukin 8 Gene Promoter Is Associated with Clostridium difficile Diarrhea
2006
Genetic and Hormonal Risk Factors in Breast Cancer
2000
Clinical outcome after early Pseudomonas aeruginosa infection in cystic fibrosis
2001
Pancreatic Cancer
2010 Standout
Genetic Modifiers of Lung Disease in Cystic Fibrosis
2005
Cisplatin in cancer therapy: Molecular mechanisms of action
2014 Standout
Occult Cancer of the Fallopian Tube in BRCA-1 Germline Mutation Carriers at Prophylactic Oophorectomy: A Case for Recommending Hysterectomy at Surgical Prophylaxis
2001
miRNA independent hepacivirus variants suggest a strong evolutionary pressure to maintain miR-122 dependence
2017 StandoutNobel
Functional promoter region polymorphism of the proinflammatory chemokine IL-8 gene associates with Parkinson's disease in the Irish
2004
Genetic Polymorphisms in Sepsis and Septic Shock
2003
Second cancers after conservative surgery and radiation for stages I–II breast cancer: identifying a subset of women at increased risk
2001
The importance of glutathione in human disease
2003 Standout
Lung disease modifier genes in cystic fibrosis
2014
Genetic polymorphisms of interleukin (IL)-1B, IL-1RN, IL-8, IL-10 and tumor necrosis factor α and risk of gastric cancer in a Chinese population
2004
Race, Breast Cancer Subtypes, and Survival in the Carolina Breast Cancer Study
2006 Standout
Antibiotic and Anti-Inflammatory Therapies for Cystic Fibrosis
2013
Pancreatic cancer
2011 Standout
Cancer of the Ovary
2004 Standout
Acute Effects of Aerosolized S -Nitrosoglutathione in Cystic Fibrosis
2002
Bronchiolitis to Asthma
2006
Pathophysiology and Management of Pulmonary Infections in Cystic Fibrosis
2003 Standout
Inflammatory Response in Airway Epithelial Cells Isolated from Patients with Cystic Fibrosis
2002
Respiratory Viral Infections in Infants: Causes, Clinical Symptoms, Virology, and Immunology
2010
Biofilms: Survival Mechanisms of Clinically Relevant Microorganisms
2002 Standout
Silver Nanoparticles Inhibit Replication of Respiratory Syncytial Virus
2008
Mucoid conversion of Pseudomonas aeruginos by hydrogen peroxide: a mechanism for virulence activation in the cystic fibrosis lung
1999
SIDS and Other Sleep-Related Infant Deaths: Expansion of Recommendations for a Safe Infant Sleeping Environment
2011 Standout
Nanozymes: Classification, Catalytic Mechanisms, Activity Regulation, and Applications
2019 Standout
Bacterial Biofilms: An Emerging Link to Disease Pathogenesis
2003 Standout
Antibiotic Resistance in Pseudomonas aeruginosa Strains with Increased Mutation Frequency Due to Inactivation of the DNA Oxidative Repair System
2009
Aggregation-Induced Emission: Together We Shine, United We Soar!
2015 Standout
Surface modification of inorganic nanoparticles for development of organic–inorganic nanocomposites—A review
2013 Standout
Receptor Binding, Fusion Inhibition, and Induction of Cross-Reactive Neutralizing Antibodies by a Soluble G Glycoprotein ofHendra Virus
2005
Clinical Practice Guideline: The Diagnosis, Management, and Prevention of Bronchiolitis
2014 Standout
Pathogenesis ofHelicobacter pyloriInfection
2006 Standout
Inflammatory Bowel Disease
2010 Standout
Markers of Response for the Antiangiogenic Agent Bevacizumab
2013
Evaluation of candidate genes MAP2K4, MADH4, ACVR1B, and BRCA2 in familial pancreatic cancer: deleterious BRCA2 mutations in 17%.
2002
Oxidative Stress: An Essential Factor in the Pathogenesis of Gastrointestinal Mucosal Diseases
2014 Standout
The Immune Response in Tuberculosis
2013 Standout
Genetic polymorphism of interleukin-8 (IL-8) is associated with Helicobacter pylori-induced duodenal ulcer.
2005
Biofilm-Related Infections: Bridging the Gap between Clinical Management and Fundamental Aspects of Recalcitrance toward Antibiotics
2014 Standout
The antioxidant role of thiocyanate in the pathogenesis of cystic fibrosis and other inflammation-related diseases
2009
Genetic Variation and Clinical Heterogeneity in Cystic Fibrosis
2011
Lung Infections Associated with Cystic Fibrosis
2002 Standout
Part 14: Pediatric Advanced Life Support
2010 Standout
Effect of Short-Term Hormone Replacement Therapy on Breast Cancer Risk Reduction After Bilateral Prophylactic Oophorectomy in BRCA1 and BRCA2 Mutation Carriers: The PROSE Study Group
2005 Standout
Breast Cancer in Men
2002 Standout
Works of J Hull being referenced
Genetic predisposition to wheeze following respiratory syncytial virus bronchiolitis
2004
Increased in vivo transcription of an IL-8 haplotype associated with respiratory syncytial virus disease-susceptibility
2004
Respiratory Syncytial Virus—Viral Biology and the Host Response
2002
Contribution of genetic factors other than CFTR to disease severity in cystic fibrosis
1998
Genetic association study for RSV bronchiolitis in infancy at the 5q31 cytokine cluster
2009
Association of respiratory syncytial virus bronchiolitis with the interleukin 8 gene region in UK families
2000
Kendig's Disorders of the Respiratory Tract in Children.
1998
Pulmonary oxidative stress response in young children with cystic fibrosis
1997
BRCA2 in American families with four or more cases of breast or ovarian cancer: recurrent and novel mutations, variable expression, penetrance, and the possibility of families whose cancer is not attributable to BRCA1 or BRCA2.
1997